Jose Ruben Garcia-Montes
Affiliations: | Cajal Institute, CSIC, Madrid |
Google:
"Jose Garcia-Montes"Mean distance: 14.65 (cluster 46) | S | N | B | C | P |
Parents
Sign in to add mentorRene Raúl Druker-Colin | grad student | Cajal Institute, CSIC, Madrid | |
Rosario Moratalla | grad student | Cajal Institute, CSIC, Madrid |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ruiz-DeDiego I, Fasano S, Solís O, et al. (2018) Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin. Scientific Reports. 8: 15381 |
García-Montes JR, Solís O, Enríquez-Traba J, et al. (2018) Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice. Molecular Neurobiology |
Suarez LM, Alberquilla S, García-Montes JR, et al. (2018) Differential synaptic remodeling by dopamine in direct and indirect striatal projection neurons in Pitx3-/- mice, a genetic model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
Solís O, García-Montes JR, Garcia-Sanz P, et al. (2017) Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice. Neurobiology of Disease |
Solís O, Garcia-Montes JR, González-Granillo A, et al. (2015) Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling. Cerebral Cortex (New York, N.Y. : 1991) |
Moratalla R, Khairnar A, Simola N, et al. (2015) Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms. Progress in Neurobiology |
Heumann R, Moratalla R, Herrero MT, et al. (2014) Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. Journal of Neurochemistry. 130: 472-89 |
García-Montes J, Boronat-García A, Drucker-Colín R. (2012) Pharmacological strategies for Parkinson's disease Health. 2012: 1153-1166 |